TY - JOUR
T1 - Allogeneic bone marrow transplantation in the developing world
T2 - Experience from a center in India
AU - Chandy, M.
AU - Srivastava, A.
AU - Dennison, D.
AU - Mathews, V.
AU - George, B.
PY - 2001
Y1 - 2001
N2 - We describe our experience of setting up an allogeneic BMT program at the Christian Medical College Hospital, Vellore over a period of 13 years, from October 1986 to December 1999. Two hundred and twenty-one transplants were performed during this period in 214 patients, with seven patients undergoing second transplants. Indication for BMT were thalassemia major - 106 (48%), CML - 30, AML - 35, ALL - 10, SAA - 22, MDS - six and six for other miscellaneous disorders. The mean age of this patient cohort was 15.6 years (range 2-52). Graft-versus-host disease of grades III and IV was seen in 36 patients (17%) and this was the primary cause of death in 20 patients (9.2%). All patients and donors were CMV IgG positive. Sepsis was the primary cause of death in 16 patients (7.4%), 10 bacterial, four fungal and two viral. One hundred and ten of this series of patients are alive and disease free (50%) with a median follow-up of 24 months (range 2-116). These results are comparable to those achieved for patients with similar disease status in transplant units in the Western world and cost a mean of US$15 000.
AB - We describe our experience of setting up an allogeneic BMT program at the Christian Medical College Hospital, Vellore over a period of 13 years, from October 1986 to December 1999. Two hundred and twenty-one transplants were performed during this period in 214 patients, with seven patients undergoing second transplants. Indication for BMT were thalassemia major - 106 (48%), CML - 30, AML - 35, ALL - 10, SAA - 22, MDS - six and six for other miscellaneous disorders. The mean age of this patient cohort was 15.6 years (range 2-52). Graft-versus-host disease of grades III and IV was seen in 36 patients (17%) and this was the primary cause of death in 20 patients (9.2%). All patients and donors were CMV IgG positive. Sepsis was the primary cause of death in 16 patients (7.4%), 10 bacterial, four fungal and two viral. One hundred and ten of this series of patients are alive and disease free (50%) with a median follow-up of 24 months (range 2-116). These results are comparable to those achieved for patients with similar disease status in transplant units in the Western world and cost a mean of US$15 000.
KW - Bone marrow transplantation
KW - Developing countries
UR - http://www.scopus.com/inward/record.url?scp=0034985411&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034985411&partnerID=8YFLogxK
U2 - 10.1038/sj.bmt.1702869
DO - 10.1038/sj.bmt.1702869
M3 - Article
C2 - 11477434
AN - SCOPUS:0034985411
SN - 0268-3369
VL - 27
SP - 785
EP - 790
JO - Bone Marrow Transplantation
JF - Bone Marrow Transplantation
IS - 8
ER -